During the last session, Bone Biologics Corp (NASDAQ:BBLG)’s traded shares were 0.38 million. At the end of the trading day, the stock’s price was $1.11, reflecting an intraday gain of 13.05% or $0.13. The 52-week high for the BBLG share is $6.34, that puts it down -471.17 from that peak though still a striking 27.93% gain since the share price plummeted to a 52-week low of $0.80. The company’s market capitalization is $2.74M, and the average intraday trading volume over the past 10 days was 0.27 million shares, and the average trade volume was 232.59K shares over the past three months.
Bone Biologics Corp (NASDAQ:BBLG) trade information
Bone Biologics Corp (BBLG) registered a 13.05% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 13.05% in intraday trading to $1.11, hitting a weekly high. The stock’s 5-day price performance is 16.84%, and it has moved by -8.26% in 30 days. Based on these gigs, the overall price performance for the year is -80.80%. The short interest in Bone Biologics Corp (NASDAQ:BBLG) is 72057.0 shares and it means that shorts have 0.18 day(s) to cover.
Bone Biologics Corp (BBLG) estimates and forecasts
Statistics show that Bone Biologics Corp has outperformed its competitors in share price, compared to the industry in which it operates. Bone Biologics Corp (BBLG) shares have gone down -5.93% during the last six months, with a year-to-date growth rate more than the industry average at 85.30% against 16.80.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 42.24%.
BBLG Dividends
Bone Biologics Corp is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Bone Biologics Corp (NASDAQ:BBLG)’s Major holders
Bone Biologics Corp insiders own 5.21% of total outstanding shares while institutional holders control 4.59%, with the float percentage being 4.84%. UBS GROUP AG is the largest shareholder of the company, while 8.0 institutions own stock in it. As of 2024-06-30, the company held over 33707.0 shares (or 5.1% of all shares), a total value of $41123.0 in shares.
The next largest institutional holding, with 17519.0 shares, is of HRT FINANCIAL LP’s that is approximately 2.6507% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $21000.0.
